NCT02166476 - Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP | Biotech Hunter

Enrollment

550

Participants

Timeline

Start Date

November 20, 2014

Primary Completion Date

April 28, 2016

Study Completion Date

April 28, 2016

Conditions

Urinary Tract Infection ComplicatedAcute Pyelonephritis

Interventions

DRUG

Meropenem-Vaborbactam

Meropenem-vaborbactam

DRUG

Piperacillin-Tazobactam

Piperacillin-tazobactam

DRUG

Levofloxacin

DRUG

Saline

Trial Locations (77)

262

San Martín de Porres

598

Ica

807

Kaohsiung City

1000

Ljubljana

1145

Budapest

1431

Sofia

1606

Sofia

3400

Montana

4204

Golnik

5500

Lovech

6100

Kharkiv

6132

Perugia

7500

Silistra

9100

Varna

9400

Sopron

10126

Torino

10676

Athens

10825

Bucharest

11527

Athens

12462

Athens

14215

Buffalo

14461

Bucharest

21018

Vinnitsa

28033

Madrid

30912

Augusta

33606

Tampa

36024

Poltava

36608

Mobile

40113

Ústí nad Labem

40138

Bologna

40705

Taichung

49005

Dnipropetrovsk

50005

Hradec Králové

50134

Florence

54636

Thessaloniki

58001

Chernivtsi

60612

Chicago

65074

Odesa

69600

Zaporizhzhia

74601

Opava

76014

Ivano-Frankivsk

76275

Zlín

80246

Denver

92120

San Diego

95123

Catania

200642

Craiova

210037

Vitebsk

220036

Minsk

220049

Minsk

224027

Brest

230017

Grodno

246027

Homyel

30170080

Belo Horizonte

08901

New Brunswick

15090-000

São José do Rio Preto

30150-221

Belo Horizonte

13060-904

Campinas

20725-090

Rio de Janeiro

SP

São Paulo

360 66

Karlovy Vary

11527 Goudi

Athens

H-6500

Baja

H-4031

Debrecen

Unknown

Arequipa

Cusco

Lima

42-200

Częstochowa

80-402

Gdansk

99-300

Kutno

05-500

Piaseczno

02-005

Warsaw

058 01

Poprad

034 26

Ružomberok

971 75

Trnava

012 07

Žilina

442-723

Gyeonggi-do

08003

Barcelona